Dexmedetomidine hydrochloride as premedication or sedative in dogs
Report of two cases
DOI:
https://doi.org/10.35172/rvz.2017.v24.235Keywords:
α2-adrenergic agonists, antagonist, sedation, analgesiaAbstract
It is reported, two cases, being the first, elective OVH surgery was performed. As MPA, 2.5
mcg/kg dexmedetomidine hydrochloride and 0.2 mg/kg IM methadone hydrochloride were
used. The anesthetic recovery was quiet and uncomplicated and the animal was extubated after
five minutes, discharged from the operating room 30 minutes later. In the second case, the third
eyelid gland was buried. As sedative, 3.5 mcg/kg of dexmedetomidine hydrochloride and as an
analgesic, 0.2 mg/kg of methadone hydrochloride IM were used. At the end of the surgical
procedure, 0.4 mcg/kg IM atipamezole hydrochloride was administered. After 15 minutes, the
patient recovered completely and could be discharge from surgery. Both procedures showed
high SBP values and bradycardia, characteristic effects of dexmedetomidine use. In the first
case, SBP remained between 150 and 180 mmHg, in the second, between 160 and 180 mmHg.
From the reported cases, it was concluded that the use of dexmedetomidine was beneficial,
providing adequate pre-anesthetic medication and sedation in these patients
References
atropina e tratados pela quetamina em associação com o midazolam ou diazepam
[dissertação]. São Paulo: Faculdade de Medicina Veterinária e Zootecnia, Universidade
Estadual Paulista; 2005.
2. Bagatini A, Gomes CR, Masella MZ, Rezer G. Dexmedetomidina: farmacologia e uso
clínico. Rev Bras Anestesiol. 2002;52(5):606-17.
3. Herbert BAG, Ramaciotti PMG, Ferrari F, Navarro LHC, Nakamura G, Rodrigues Jr GR et
al. Uso de dexmedetomidina em neurocirurgia. Rev Bras Anestesiol. 2007;57(2):223-31.
4. Butterworth JS, Strichartz GR. The α2-adrenergic agonists clonidine e guanfacine produce
tonic and phasic block and conduction in rat sciatic nerve fibers. Anesth Analg.
1993;76(2):295-301.
5. Kamibayashi T, Maze M. Clinical uses of α2-adrenergic agonists. Anesthesiology.
2000;93(5):1345-9.
6. Bouret S, Sara SJ. Locus coeruleus. Scholarpedia. 2010;5(3):2845.
7. Alves TCA, Braz JRC, Vianna PTG. α2-Agonistas em anestesiologia: aspectos clínicos e
farmacológicos. Rev Bras Anestesiol. 2000;50(5):396-404.
8. Bylund DB. α2 adrenoceptor subtypes: are more better? Br J Pharmacol. 2005;144(2):159-
60.
9. Fantoni DT, Cortopassi SRG. Medicação pré-anestésica. In: Fantoni DT, Cortopassi SRG.
Anestesia em cães e gatos. São Paulo: Roca; 2002. p.151-8.
10. Ruffolo Jr RR, Nichols AJ, Stadel J, Hieble JP. Pharmacology and therapeutic applications
of α2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol. 1993;33:243-279.
11. Flôres FN, Moraes AN, Oleskovicz N, Oliveira F, Bortoluzzi N, Minsky V, et al. Sulfato
de atropina nos parâmetros hemodinâmicos e hemogasométricos de cães anestesiados com
clorpromazina, dexmedetomidina e isoflurano. Cienc Rural. 2008;38(4):1024-9.
12. Magalhães E, Gouvêia CS, Ladeira LCA, Espíndola BV. Relação entre a infusão contínua
de dexmedetomidina e a fração expirada de sevoflurano monitorizada pelo índice
bispectral. Rev Bras Anestesiol. 2004;54(3):303-10.
13. Vainio O, Vahe-vahe T. Reversal of medetomidine sedation by atipamezole in dogs. J Vet
Pharmacol Ther. 1990;13(1):15-22.
Downloads
Published
How to Cite
Issue
Section
License
Este obra está licenciado com uma Licença Creative Commons Atribuição-NãoComercial 4.0 Internacional.
